You are here

  • Home
  • Archive
  • Volume 30, Issue Suppl 3
  • 1 Avelumab in combination with and/or following chemotherapy vs chemotherapy in treatment-naive patients with ovarian cancer: biomarker analyses from the phase 3 JAVELIN Ovarian 100 trial

Citation Tools

Article menu

Download PDFPDF

Oral Plenary
Plenary I
IGCS20_1256
1 Avelumab in combination with and/or following chemotherapy vs chemotherapy in treatment-naive patients with ovarian cancer: biomarker analyses from the phase 3 JAVELIN Ovarian 100 trial
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Ledermann J, Colombo N, Oza A, et al
1 Avelumab in combination with and/or following chemotherapy vs chemotherapy in treatment-naive patients with ovarian cancer: biomarker analyses from the phase 3 JAVELIN Ovarian 100 trial
International Journal of Gynecologic Cancer 2020;30:A1.